Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Apr;15(4):210-7.
doi: 10.1038/gene.2014.6. Epub 2014 Mar 6.

MHC associations with clinical and autoantibody manifestations in European SLE

Collaborators, Affiliations
Meta-Analysis

MHC associations with clinical and autoantibody manifestations in European SLE

D L Morris et al. Genes Immun. 2014 Apr.

Abstract

Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease affecting multiple organ systems and characterized by autoantibody formation to nuclear components. Although genetic variation within the major histocompatibility complex (MHC) is associated with SLE, its role in the development of clinical manifestations and autoantibody production is not well defined. We conducted a meta-analysis of four independent European SLE case collections for associations between SLE sub-phenotypes and MHC single-nucleotide polymorphism genotypes, human leukocyte antigen (HLA) alleles and variant HLA amino acids. Of the 11 American College of Rheumatology criteria and 7 autoantibody sub-phenotypes examined, anti-Ro/SSA and anti-La/SSB antibody subsets exhibited the highest number and most statistically significant associations. HLA-DRB1*03:01 was significantly associated with both sub-phenotypes. We found evidence of associations independent of MHC class II variants in the anti-Ro subset alone. Conditional analyses showed that anti-Ro and anti-La subsets are independently associated with HLA-DRB1*0301, and that the HLA-DRB1*03:01 association with SLE is largely but not completely driven by the association of this allele with these sub-phenotypes. Our results provide strong evidence for a multilevel risk model for HLA-DRB1*03:01 in SLE, where the association with anti-Ro and anti-La antibody-positive SLE is much stronger than SLE without these autoantibodies.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
HLA-DRB1*03:01 dosage (average number of alleles observed) over levels of disease (a): (healthy controls/anti-Ro( −)/anti-Ro( +)); (b): (healthy controls/anti-La( −)/anti-La( +)); (c) (healthy controls/anti-Ro( −) AND anti-La( −)/anti-Ro( +) AND anti-La( +)/). Average dosage is represented by a square, whereas upper and lower 95% confidence intervals are represented by ‘ −’. Note that dosage ranges from 0 to 2 for each subject and so to convert to allele frequency you must divide by 2. All three plots have been truncated at 1.

References

    1. Guerra SG, Vyse TJ, Graham DSC. The genetics of lupus: a functional perspective. Arthritis Res Ther. 2012;14:211. - PMC - PubMed
    1. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Royburman P, et al. A revised estimate of twin concordance in systemic lupus-erythematosus. Arthritis Rheum. 1992;35:311–318. - PubMed
    1. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1177 lupus patients from the GLADEL cohort. Arthritis Rheum. 2005;52:1138–1147. - PubMed
    1. Lawrence JS, Martins CL, Drake GLA. Family survey of lupus-erythematosus.1. Heritability. J Rheumatol. 1987;14:913–921. - PubMed
    1. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40:204–210. - PMC - PubMed

Publication types

Grants and funding